Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Feenstra

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 8, 2001
Hereditary otovestibular dysfunction and Ménière's disease in a large Belgian family is caused by a missense mutation in the COCH geneM Verstreken, F Declau, F L Wuyts, et al.
Health Economics|December 3, 2014
Dealing With Missing Behavioral Endpoints in Health Promotion Research by Modeling Cognitive Parameters in Cost-Effectiveness Analyses of Behavioral Interventions: A Validation StudyRilana Prenger, Marcel E Pieterse, Louise M A Braakman-Jansen, et al.
Maturitas|May 22, 2018
Corrigendum to "A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening" [Maturitas 109 (2018) 81-88]Rositsa G Koleva-Kolarova, Alicja M Daszczuk, Chris de Jonge, et al.
Zoonoses and Public Health|November 14, 2017
The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approachA W M Suijkerbuijk, P F van Gils, A A Bonačić Marinović, et al.
Maturitas|February 18, 2018
A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screeningRositsa G Koleva-Kolarova, Alicja M Daszczuk, Chris de Jonge, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 26, 2020
Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatmentEliza R C Hagens, Minke L Feenstra, Maarten A van Egmond, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenariosMartine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 14, 2013
[Societal costs of asthma, COPD and respiratory allergy]Anita W M Suijkerbuijk, G A Ardine de Wit, Alet H Wijga, et al.
Diabetologia|April 5, 2020
Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care settingAmber A van der Heijden, Giel Nijpels, Fariza Badloe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjectsJ G Slatter, D J Stalker, K L Feenstra, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 8, 2001
Hereditary otovestibular dysfunction and Ménière's disease in a large Belgian family is caused by a missense mutation in the COCH geneM Verstreken, F Declau, F L Wuyts, et al.
Health Economics|December 3, 2014
Dealing With Missing Behavioral Endpoints in Health Promotion Research by Modeling Cognitive Parameters in Cost-Effectiveness Analyses of Behavioral Interventions: A Validation StudyRilana Prenger, Marcel E Pieterse, Louise M A Braakman-Jansen, et al.
Maturitas|May 22, 2018
Corrigendum to "A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening" [Maturitas 109 (2018) 81-88]Rositsa G Koleva-Kolarova, Alicja M Daszczuk, Chris de Jonge, et al.
Zoonoses and Public Health|November 14, 2017
The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approachA W M Suijkerbuijk, P F van Gils, A A Bonačić Marinović, et al.
Maturitas|February 18, 2018
A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screeningRositsa G Koleva-Kolarova, Alicja M Daszczuk, Chris de Jonge, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 26, 2020
Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatmentEliza R C Hagens, Minke L Feenstra, Maarten A van Egmond, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenariosMartine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 14, 2013
[Societal costs of asthma, COPD and respiratory allergy]Anita W M Suijkerbuijk, G A Ardine de Wit, Alet H Wijga, et al.
Diabetologia|April 5, 2020
Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care settingAmber A van der Heijden, Giel Nijpels, Fariza Badloe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjectsJ G Slatter, D J Stalker, K L Feenstra, et al.
Pageof 26